Europe Migraine Epidemiology and Patient Flow Analysis - 2018

  • ID: 4516602
  • Report
  • Region: Europe
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The researcher announced the results of its Migraine patients study in a new research ‘Europe Migraine Epidemiology and Patient Flow Analysis - 2018’. The research provides insights into Migraine epidemiology, Migraine diagnosed patients, and Migraine treatment rate for EU5 countries. The research measures key indicators including prevalence of Migraine derived from epidemiological analysis, patients diagnosed with Migraine, and patients treated with a drug therapy.

The research study helps executives estimate Migraine market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Migraine prevalence, Migraine diagnosis rate, and Migraine treatment rate for the period 2017 - 2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Features of the Report:
  • Migraine Patient Flow
  • Migraine Prevalence
  • Migraine Diagnosed Patients
  • Migraine Treated Patients
Note: Product cover images may vary from those shown
2 of 3
1. Migraine: Disease Definition
2. Migraine Patient Flow in Europe
2A. Migraine Prevalence in Europe
2B. Migraine Diagnosed Patients in Europe
2C. Migraine Treated Patients in Europe
3. Migraine Patient Flow in Germany
3A. Migraine Prevalence in Germany
3B. Migraine Diagnosed Patients in Germany
3C. Migraine Treated Patients in Germany
4. Migraine Patient Flow in France
4A. Migraine Prevalence in France
4B. Migraine Diagnosed Patients in France
4C. Migraine Treated Patients in France
5. Migraine Patient Flow in Spain
5A. Migraine Prevalence in Spain
5B. Migraine Diagnosed Patients in Spain
5C. Migraine Treated Patients in Spain
6. Migraine Patient Flow in Italy
6A. Migraine Prevalence in Italy
6B. Migraine Diagnosed Patients in Italy
6C. Migraine Treated Patients in Italy
7. Migraine Patient Flow in UK
7A. Migraine Prevalence in UK
7B. Migraine Diagnosed Patients in UK
7C. Migraine Treated Patients in UK
8. Research Methodology

List of Tables
Table 1: Migraine Patient Flow in Europe, 2017
Table 2: Migraine Patient Flow Forecast in Europe, 2017 - 2026
Table 3: Migraine Patient Flow in Germany, 2017
Table 4: Migraine Patient Flow Forecast in Germany, 2017 - 2026
Table 5: Migraine Patient Flow in France, 2017
Table 6: Migraine Patient Flow Forecast in France, 2017 - 2026
Table 7: Migraine Patient Flow in Spain, 2017
Table 8: Migraine Patient Flow Forecast in Spain, 2017 - 2026
Table 9: Migraine Patient Flow in Italy, 2017
Table 10: Migraine Patient Flow Forecast in Italy, 2017 - 2026
Table 11: Migraine Patient Flow in UK, 2017
Table 12: Migraine Patient Flow Forecast in UK, 2017 - 2026

List of Figures
Figures 1: Migraine Patient Flow in Europe, 2017
Figure 2: Migraine Patient Flow Forecast in Europe, 2017 - 2026
Figure 3: Migraine Patient Flow in Germany, 2017
Figure 4: Migraine Patient Flow Forecast in Germany, 2017 - 2026
Figure 5: Migraine Patient Flow in France, 2017
Figure 6: Migraine Patient Flow Forecast in France, 2017 - 2026
Figure 7: Migraine Patient Flow in Spain, 2017
Figure 8: Migraine Patient Flow Forecast in Spain, 2017 - 2026
Figure 9: Migraine Patient Flow in Italy, 2017
Figure 10: Migraine Patient Flow Forecast in Italy, 2017 - 2026
Figure 11: Migraine Patient Flow in UK, 2017
Figure 12: Migraine Patient Flow Forecast in UK, 2017 - 2026
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll